Longevity advice is written as if everyone faces the same problem. They do not. A 28-year-old sleeping five hours a night and a 68-year-old losing grip strength both benefit from "healthy habits," but almost nothing about their priority order is the same. The intervention with the largest effect for one produces a rounding error for the other.
These four guides start from the constraint that is actually binding — time, hormonal decline, functional capacity, or simply not knowing where to begin — and route from there to the biomarkers, interventions, and platform options that fit. The comparison below is the fastest way to find yours.
The Verdict
The four guides, side by side
Listed alphabetically. Budgets are typical annual ranges for testing and program fees, excluding medication and equipment. Biomarkers listed are the ones most likely to change a decision for that audience, not a complete panel.
| Guide | Primary concern | Highest-leverage intervention | Key biomarkers | Typical budget |
|---|---|---|---|---|
| Beginners | Not knowing which of a hundred recommendations matters | Fix sleep duration and start resistance training twice a week | Fasting insulin, HbA1c, ApoB, vitamin D, a full thyroid panel | $0–$500/year |
| Busy professionals | Time, not money — 60 minutes a week to spend on health | Protect sleep window first; compress training into two 45-minute sessions | hsCRP, fasting insulin, ApoB, morning cortisol, free testosterone | $500–$3,000/year |
| Men over 40 | Declining energy, body composition, and libido with "normal" labs | Full hormone panel including SHBG and free testosterone, then treat what it shows | Total and free testosterone, SHBG, estradiol, LH, PSA, ApoB | $1,200–$5,000/year |
| Retirees | Losing functional independence — muscle, balance, cognition | Resistance training plus 1.0–1.2g protein per kg body weight daily | ApoB, Lp(a), HbA1c, vitamin D, B12, hsCRP, DEXA body composition | $500–$2,500/year |
Why priorities diverge by life stage
Three things change with age, and they change the math on every intervention.
The limiting factor moves. Before about 40, most people are limited by behavior rather than biology. Adding a blood panel to someone sleeping six hours and training zero times a week does not change what they should do next. After 40, hormonal decline and accumulating arterial burden become measurable and treatable, so testing starts to alter decisions rather than confirm them.
The time horizon shortens, which raises the value of some interventions and lowers others. Lp(a) screening at 30 informs 50 years of decisions. The same test at 75 informs far fewer. Resistance training runs the opposite way: sarcopenia costs roughly 3–8% of muscle mass per decade after 30, and the rate accelerates after 60, so the absolute benefit of lifting is highest in the decade most people stop.
The failure mode changes. Younger adults fail at consistency. Older adults fail at recovery capacity and at the cost of a single adverse event — a fall, a fracture, a hospitalization. That is why balance and muscle mass sit above lipid optimization in the retirement decade, despite lipids getting far more coverage.
How to self-select into the right guide
- You have never tracked anything and the advice feels endless. Start with beginners. It covers what to fix before spending anything, and what a sensible first panel looks like.
- You know what to do and cannot find the hours. Start with busy professionals. It ranks interventions by benefit per minute and flags the programs that require compliance you will not deliver.
- Your labs are "normal" and you feel worse than you did five years ago. Start with men over 40. The normal-total, high-SHBG, low-free testosterone pattern is the most common explanation, and it is invisible on a standard panel.
- Maintaining independence is the goal. Start with retirees. It leads with muscle, protein, balance, and cognition, then covers the cardiovascular and metabolic markers that still matter.
Matching budget to program type
Across every audience, the cost driver is not biomarker count. It is whether a clinician is included and how often you retest. A program retesting quarterly costs several times one retesting annually for the same panel.
| Annual budget | What it typically buys | Fits if |
|---|---|---|
| Under $500/year | Direct-to-consumer panel once or twice a year, self-interpreted | You are comfortable reading results against reference targets yourself |
| $500–$1,500/year | Broad panel plus a paid consult to review it | You want one expert read but not ongoing management |
| $1,500–$5,000/year | Physician-led program with quarterly retesting and a prescription pathway | You have a specific pattern to treat, not just curiosity |
| $5,000+/year | Concierge or clinic-based program with imaging and in-person visits | Screening breadth and access matter more than cost efficiency |
Prescription costs sit outside all of these ranges and are frequently the largest line item. Testosterone therapy, GLP-1 medications, and peptide protocols can each exceed the program fee itself. Any budget built from a platform's advertised subscription price will understate the real total if a prescription pathway is part of the plan.
Audience guides
- Longevity for beginners — what to fix first, and what a sensible first panel costs
- Longevity for busy professionals — the time-efficient approach, ranked by benefit per minute
- Longevity for men over 40 — biomarkers, hormone therapy, and how the platforms compare
- Longevity for retirement — muscle, cardiovascular, cognitive, and hormonal priorities
Related
- Biomarker guides — target ranges and retest cadence by system
- Doctor-led options — programs that include a clinician review
- Longevity platforms compared — every platform on the same rubric, alphabetically
- Methodology — how prices, hidden costs, and scores are verified
Frequently Asked Questions
Why do longevity priorities change by life stage?
Because the constraint changes. In your twenties and thirties the limiting factor is usually habit formation — sleep, training, and alcohol account for most of the achievable gain, and testing adds little. From the forties on, hormonal decline and accumulating cardiovascular risk become measurable, so testing starts to change decisions. In the retirement decade the dominant risk shifts to loss of function: muscle mass, balance, and cognition. The same intervention has very different value at each of those stages.
Which guide should I read if more than one fits me?
Pick the guide matching your tightest constraint rather than your demographic. A 45-year-old man working 70-hour weeks gets more from the busy-professionals guide than the men-over-40 guide, because time is what is actually limiting him. A 68-year-old still training hard may find the men-over-40 hormone content more relevant than the retirees guide. The guides overlap deliberately; read the second one after you have acted on the first.
How much should I expect to spend on longevity testing?
Entry-tier direct-to-consumer panels run roughly $250–$500 per year. Physician-led programs with quarterly retesting run roughly $1,200–$5,000 per year before medication costs. Clinic-based concierge programs start near $19,500 per year. The largest cost driver is not biomarker count but whether a clinician is included and how often you retest — a program retesting every 3 months costs several times one retesting annually, for the same panel.
Do I need a longevity platform at all?
Not to start. Sleep duration, resistance training, protein intake, alcohol reduction, and blood pressure control are free or nearly free, and they account for most of the achievable benefit for someone who has not addressed them. Testing becomes worth paying for when you have exhausted the free interventions, when symptoms persist despite them, or when you need a baseline before starting something with real risk, such as hormone therapy.
What is the most common mistake at each stage?
Beginners buy a 100-marker panel before fixing sleep, then have no idea which of forty flagged values matters. Busy professionals buy a program they have no time to comply with. Men over 40 test total testosterone alone, get a normal number, and stop — missing high SHBG and low free testosterone. Retirees focus on cardiovascular markers while ignoring muscle mass and balance, which are the stronger predictors of independence in that decade.
Are these guides medical advice?
No. They are editorial comparisons of products, priorities, and testing options. They do not diagnose conditions, prescribe treatment, or replace a clinician who knows your history. Anyone with a flagged result, an existing diagnosis, or a prescription medication should review any plan with a physician before changing it.